Your Doctor Checks Your Cholesterol. They Should Also Be Checking These Two Numbers.
Nearly everyone knows their cholesterol. Almost nobody knows their hs-CRP or IL-6 — the two markers that predict your 10-year health trajectory more accurately. Here's what they are, what they reveal, and exactly how to get them tested.
Everyone Knows Their Cholesterol Number. Almost Nobody Knows Their CRP.
The cholesterol screening narrative is one of medicine's most successful public health campaigns. Most adults over 40 know whether their LDL is elevated. They've had the conversation with their doctor. They understand — broadly — that cholesterol is relevant to cardiovascular risk.
What fewer people know: the 2008 JUPITER trial (Justification for the Use of Statins in Prevention) enrolled 17,802 apparently healthy adults with normal LDL cholesterol but elevated hs-CRP. The trial had to be stopped early because the difference in cardiovascular outcomes between treated and untreated groups was so dramatic. The finding: elevated hs-CRP predicted cardiovascular events — heart attacks, strokes — in people whose cholesterol panels looked completely fine.
This is not a fringe result. It has been replicated across multiple prospective cohorts. hs-CRP adds predictive value over and above the lipid panel for cardiovascular events, cognitive decline, and all-cause mortality. The American Heart Association's joint statement on CRP and cardiovascular risk — published 15 years ago — explicitly recommended hs-CRP as a risk stratification tool. Most general practitioners still don't routinely order it.
"The JUPITER trial didn't just change how cardiologists think about CRP. It raised a more uncomfortable question: what else are we measuring wrong?"
hs-CRP: What the Optimal Range Actually Means for Your Aging Trajectory
Standard clinical CRP testing uses a reference range calibrated to detect acute inflammation from infection or injury — with "high" typically defined as above 10 mg/L. This threshold is clinically useful for detecting active disease. It is entirely inadequate for detecting the chronic low-grade inflammaging that accelerates biological aging over decades.
High-sensitivity CRP (hs-CRP) can detect concentrations as low as 0.1 mg/L — the range where longevity research actually operates. The major cardiovascular studies that established CRP's predictive value all used hs-CRP. The ranges that matter for aging:
Where are most people in their 40s and 50s? Population studies consistently show mean hs-CRP values of 1.5–3.5 mg/L in otherwise healthy adults in this age range. The majority sit in the "suboptimal" zone — which the lab reports as normal, because it is below the disease-detection threshold — but which represents meaningful inflammatory aging acceleration over time.
IL-6: The Signal That Drives CRP. And Why You Want to Know Both.
Interleukin-6 is one level upstream from CRP in the inflammatory cascade. When cellular stressors — senescent cells, damaged mitochondria, gut permeability — generate inflammatory signals, IL-6 is among the first cytokines secreted. IL-6 then travels to the liver and triggers CRP production. This means IL-6 is more causally proximal to the actual inflammatory drivers than CRP is.
In practical terms: if CRP is elevated, IL-6 is almost certainly elevated. If IL-6 is elevated, CRP will follow. But the relationship is not perfectly linear — IL-6 fluctuates faster in response to acute changes, while CRP reflects a more integrated signal over days. Measuring both gives you a more complete picture of both the immediate cellular inflammatory activity and the sustained systemic inflammatory load.
IL-6 is less commonly included in routine panels but is available from all major reference labs. Functional medicine and longevity-focused physicians routinely order it. The standard reference range for IL-6 is typically 0–7 pg/mL for laboratory detection purposes. For longevity optimization, values above 2.0 pg/mL in otherwise healthy adults warrant attention. The Igniton™ study participants averaged 1.39 pg/mL at baseline — in the optimizable range — and dropped to 0.88 pg/mL in 30 days with the quantum-enhanced formula.
How to request IL-6: Ask your physician for "serum IL-6" or "interleukin-6." It is frequently included in comprehensive inflammation panels from labs like Quest Diagnostics and LabCorp. Cost: approximately $25–50. If your physician is unfamiliar with ordering it for longevity monitoring, a direct-to-consumer lab like Ulta Lab Tests or Function Health includes it in inflammation panels.
These Markers Moved in 30 Days. Here's the Data.**
The 2025 Igniton™ clinical study (Valverde, Gavrilova, Churganov & Korotkov, Int. J. Studies in Psychology) measured hs-CRP and IL-6 as primary outcomes in 70 adults aged 50±14 years over 30 days. Three groups: quantum-enhanced formula, same formula without enhancement, placebo.
Enhanced Group: Both Inflammatory Markers Moved to Statistically Significant Levels**
IL-6: 1.39 → 0.88 pg/mL · p < 0.01 · 37% reduction from baseline
CRP: 2.13 → 1.54 mg/L · p < 0.01 · 28% reduction from baseline
Unenhanced group (identical compounds, no quantum processing): No statistically significant changes in either IL-6 or CRP. The enhancement is not cosmetic — it is the mechanism by which bioavailability becomes sufficient to move these markers.
The baseline CRP of 2.13 mg/L in participants represents the common "suboptimal" zone described above. The 30-day endpoint of 1.54 mg/L represents movement from the suboptimal zone toward the optimal range. The clinical relevance of this magnitude of change is well-established in the cardiovascular and longevity literature.
IgniLongevity™ moved hs-CRP and IL-6 in a controlled 30-day trial.
The two markers your doctor rarely orders — the ones that actually predict your aging trajectory. Clinical data. Not marketing claims.**
